Keliximab (anti-CD4) with a Ki value of 1.0 nM for soluble CD4. Keliximab (anti-CD4) blocks T cell proliferation and inhibits IL-2 production. Keliximab (anti-CD4) can be used for cancer research.
Specification: Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, ≥95%(SDS-PAGE&SEC-HPLC), Lot by Lot
Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/AB191955-SCI_919d02bd90beb942a2f8eb0d06924714.pdf
- UPC:
- 51111643
- Condition:
- New
- Availability:
- 4-8 weeks
- Weight:
- 0.07 Ounces
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- Ab191955-100μg
- CAS:
- 174722-30-6
- Product Size:
- 100μg